Why carry out this study?

With new therapies for adult patients with moderate to severe AD in European countries, the need to better understand the burden of disease and real-world treatment patterns for this patient population remains of key importance.

This country-specific analysis provides insights from a patient–physician survey on patient and disease characteristics, including current flare status, treatment patterns, and comorbidities, and describes PROs in adults with moderate to severe AD.

What was learned from the study?

Results of the analysis indicate that adult patients with moderate to severe AD have a significant disease burden and unmet treatment needs, including the under-utilization of systemic treatments, despite AD being a systemic disease.

Findings of the current analysis are supported by those of previously conducted analyses, including a large European prospective observational study and other retrospective real-world studies in patients with moderate to severe AD.